SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nuvelo (Nasdaq: NUVO)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (54)9/8/1999 12:07:00 AM
From: Larry Liebman  Read Replies (2) of 286
 
Opened a position at $3 1/4. HYSQ appears to be trading around book value. Went to CHIR site and found the comment "...60,000 genetic sequences identified...HYSQ and CHIR have built one of the world's largest proprietary cancer gene databases". In addition, their deal with Kirin appears to retain all rights for discoveries within the U.S. market. With 13 million/sh at $3.50 and a cap of $45 million it barely makes it onto the screen of biotech analysts. However, with the moves MLNM, AFFX, etc., have made, I've got to wonder if this is a timely equity to own. Thoughts appreciated.

P.S. The fellow who opened this thread on 8.6.97 gives the I.P.O. at $12-$14!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News